(Q53331692)

13 May 2018

title

Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models. (English)

1 reference

13 May 2018

1 reference

hepatocellular carcinoma

1 reference

1 reference

Desnoyers LR

1

1 reference

13 May 2018

Pai R

2

1 reference

13 May 2018

Ferrando RE

3

1 reference

13 May 2018

Hötzel K

4

1 reference

13 May 2018

Le T

5

1 reference

13 May 2018

Ross J

6

1 reference

13 May 2018

Carano R

7

1 reference

13 May 2018

D'Souza A

8

1 reference

13 May 2018

Qing J

9

1 reference

13 May 2018

Mohtashemi I

10

1 reference

13 May 2018

Ashkenazi A

11

1 reference

13 May 2018

French DM

12

1 reference

13 May 2018

language of work or name

English

0 references

publication date

25 June 2007

1 reference

13 May 2018

published in

Oncogene

1 reference

13 May 2018

volume

27

1 reference

13 May 2018

issue

1

1 reference

13 May 2018

page(s)

85-97

1 reference

13 May 2018

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

Cellular signaling by fibroblast growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

The crystal structure of fibroblast growth factor (FGF) 19 reveals novel features of the FGF family and offers a structural basis for its unusual receptor affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

Amplification of fgfr4 gene in human breast and gynecological cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

Fibroblast growth factors in cancer: therapeutic possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

FGF-2 abnormalities in B cell chronic lymphocytic and chronic myeloid leukemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

Increased expression of fibroblast growth factor 8 in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

FGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

Fibroblast growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

Receptor specificity of the fibroblast growth factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

Fibroblast growth factors, their receptors and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

Common and distinct elements in cellular signaling via EGF and FGF receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

Identification of a new fibroblast growth factor receptor, FGFR5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

Fibroblast growth factor receptor (FGFR) 4 correlated with the malignancy of human astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

Independent repression of bile acid synthesis and activation of c-Jun N-terminal kinase (JNK) by activated hepatocyte fibroblast growth factor receptor 4 (FGFR4) and bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

Functional FGFR4 Gly388Arg Polymorphism Predicts Prognosis in Lung Adenocarcinoma Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

Precancerous changes in the human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

7 January 2021

PDGF alpha- and beta-receptors activate unique and common signal transduction pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

7 January 2021

Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

7 January 2021

FGF4 and INT2 oncogenes are amplified and expressed in Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

7 January 2021

CT depiction of experimental liver tumors: contrast enhancement with hepatocyte-selective iodinated triglyceride versus conventional techniques

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

7 January 2021

Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high‐grade soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210623

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210623

1 reference

13 May 2018

1 reference

13 May 2018